(Q36141458)

12 August 2017

1 reference

title

Should nonalcoholic fatty liver disease be renamed? (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

12 August 2017

1 reference

1 reference

1 reference

Paola Loria

1

1 reference

12 August 2017

Amedeo Lonardo

series ordinal

2

1 reference

12 August 2017

Nicola Carulli

series ordinal

3

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

23

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

72-82

1 reference

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

12 August 2017

cites work

1 reference

Non-alcoholic steatohepatitis: definitions and pathogenesis

21 January 2018

1 reference

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

21 January 2018

1 reference

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

21 January 2018

1 reference

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

Subacute liver failure in obese women

21 January 2018

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study

21 January 2018

1 reference

The association of fatty liver and diabetes risk

21 January 2018

1 reference

Interaction of non-alcoholic fatty liver disease with other liver diseases.

21 January 2018

1 reference

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

21 January 2018

1 reference

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

Hepatic steatosis as a potential risk factor for major hepatic resection

21 January 2018

1 reference

Fatty liver in liver transplantation and surgery

21 January 2018

1 reference

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

21 January 2018

1 reference

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

Body fat topography as an independent predictor of fatty liver

21 January 2018

1 reference

Fatty infiltration of liver in hyperlipidemic patients

21 January 2018

1 reference

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

21 January 2018

1 reference

Hepatic steatosis, insulin resistance, and adipose tissue disorders.

21 January 2018

1 reference

Risk factors of fibrosis in alcohol-induced liver disease

21 January 2018

1 reference

Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?

21 January 2018

1 reference

Lipid overload and overflow: metabolic trauma and the metabolic syndrome

21 January 2018

1 reference

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

21 January 2018

1 reference

Regulation of fatty acid homeostasis in cells: novel role of leptin

21 January 2018

1 reference

Lipotoxicity: when tissues overeat

21 January 2018

1 reference

Serum leptin levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

21 January 2018

1 reference

Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis.

21 January 2018

1 reference

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

21 January 2018

1 reference

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

Insulin resistance in non-alcoholic steatohepatitis

21 January 2018

1 reference

Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

21 January 2018

1 reference

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases

21 January 2018

1 reference

Liver pathology and the metabolic syndrome X in severe obesity.

21 January 2018

1 reference

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

21 January 2018

1 reference

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

Recurrence of insulin resistant metabolic syndrome following liver transplantation

21 January 2018

1 reference

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population

21 January 2018

1 reference

Orlistat in the treatment of NASH: a case series

21 January 2018

1 reference

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?

21 January 2018

1 reference

A resistance movement in NASH.

21 January 2018

1 reference

The liver in obesity and type 2 diabetes mellitus

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

21 January 2018

1 reference

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

21 January 2018

1 reference

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

21 January 2018

1 reference

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

Weighty issues in hepatitis C

21 January 2018

1 reference

Pathogenesis of type 2 diabetes. Insulin resistance

21 January 2018

1 reference

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

21 January 2018

1 reference

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084728

1 reference

12 August 2017

1 reference